Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel Yamanouchi compound activates gene expression, translocation of Glut4

Dec. 18, 2000

AeroGen begins phase II clinical trials with AeroDose insulin inhaler

Dec. 18, 2000

Potential new contraceptive agents patented by Schering

Dec. 15, 2000

FDA requests additional data to support Dynepo BLA

Dec. 15, 2000

AHP and Ligand report preparation and use of new progesterone receptor modulators

Dec. 14, 2000

Japanese research team discovers new PTP inhibitors for diabetes

Dec. 14, 2000

AHL-157, a new fibrate with promising hypolipidemic and hypoglycemic effects

Dec. 14, 2000

SB commences clinical development of calcilytics for treatment of osteoporosis

Dec. 14, 2000

Pola's new ACAT inhibitors described in patent literature

Dec. 13, 2000

AHP and Ligand collaboration focuses on progesterone receptor modulators

Dec. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...